Characterization of the novel protein P9TLDR (temporal lobe down-regulated) with a brain-site-specific gene expression modality in Alzheimer's disease brain

FEBS Letters

Volumn 586, Issue 24, 2012, Pages 4357-4361

  Yokota, Tomoko ^a   Akatsu, Hiroyasu ^b   Miyauchi, Takashi ^a   Heese, Klaus ^c  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c Hanyang University   (South Korea)

Author keywords

Alzheimer's disease; Amyloid; Brain; Mapt; Neurodegeneration; Neurotoxicity; Tau

Indexed keywords

AMYLOID BETA PROTEIN; BRAIN PROTEIN; COMPLEMENTARY DNA; PROTEIN P9TLDR; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE ISOLATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MICROTUBULE; MOLECULAR MODEL; NERVE CELL; NUCLEOTIDE SEQUENCE; OCCIPITAL LOBE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; TEMPORAL CORTEX; TEMPORAL LOBE; TISSUE SPECIFICITY;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; PHOSPHORYLATION; TAU PROTEINS; TEMPORAL LOBE;

EID: 84870565960     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.10.050     Document Type: Article

References (37)

1. M.B. Graeber Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis Neurogenetics 1 1997 73 80
2. M.P. Mattson Pathways towards and away from Alzheimer's disease Nature 430 2004 631 639
3. C. Holscher Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies Rev. Neurosci. 16 2005 181 212
4. K. Heese, and H. Akatsu Alzheimer's disease-an interactive perspective Curr. Alzheimer Res. 3 2006 109 121
5. D.J. Selkoe, and D. Schenk Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics Annu. Rev. Pharmacol. Toxicol. 43 2003 545 584
6. D.J. Selkoe Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases Nat. Cell Biol. 6 2004 1054 1061
7. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol. 82 1991 239 259
8. G. Lace Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study Brain 132 2009 1324 1334
9. C. Duyckaerts, B. Delatour, and M.C. Potier Classification and basic pathology of Alzheimer disease Acta Neuropathol. 118 2009 5 36
10. P.T. Nelson, H. Braak, and W.R. Markesbery Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship J. Neuropathol. Exp. Neurol. 68 2009 1 14
11. W. Cao Comparing gene discovery from Affymetrix GeneChip microarrays and Clontech PCR-select cDNA subtraction: a case study BMC Genomics 5 2004 26
12. T. Yokota Brain site-specific gene expression analysis in Alzheimer's disease patients Eur. J. Clin. Invest. 36 2006 820 830
13. L. Diatchenko Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries Proc. Natl. Acad. Sci. USA 93 1996 6025 6030
14. L. Diatchenko, S. Lukyanov, Y.F. Lau, and P.D. Siebert Suppression subtractive hybridization: a versatile method for identifying differentially expressed genes Methods Enzymol. 303 1999 349 380
15. M. Mishra, N. Inoue, and K. Heese Characterizing the novel protein p33MONOX Mol. Cell. Biochem. 350 2011 127 134
16. Y. Nagai, A. Ogasawara, and K. Heese Possible mechanisms of A beta(1-40)- or A beta(1-42)-induced cell death and their rescue factors Nihon Yakurigaku Zasshi 124 2004 135 143
17. K. Heese, Y. Nagai, and T. Sawada Identification of a new synaptic vesicle protein 2B mRNA transcript which is up-regulated in neurons by amyloid beta peptide fragment (1-42) Biochem. Biophys. Res. Commun. 289 2001 924 928
18. H. Braak, and E. Braak Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis Acta Neuropathol. 92 1996 197 201
19. H. Braak, and E. Braak Frequency of stages of Alzheimer-related lesions in different age categories Neurobiol. Aging 18 1997 351 357
20. H. Braak, and E. Braak Staging of Alzheimer-related cortical destruction Int. Psychogeriatr. 9 Suppl 1 1997 257 261 discussion 269-272
21. H. Braak, E. Braak, and J. Bohl Staging of Alzheimer-related cortical destruction Eur. Neurol. 33 1993 403 408
22. H. Braak, D.R. Thal, E. Ghebremedhin, and K. Del Tredici Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years J. Neuropathol. Exp. Neurol. 70 2011 960 969
23. S.S. Mirra The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 41 1991 479 486
24. M. Mishra, H. Akatsu, and K. Heese The novel protein MANI modulates neurogenesis and neurite-cone growth J. Cell. Mol. Med. 15 2011 1713 1725
25. H. Akatsu Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital J. Neurol. Sci 196 2002 63 69
26. H. Akatsu TAFI polymorphisms at amino acids 147 and 325 are not risk factors for cerebral infarction Br. J. Haematol. 127 2004 440 447
27. S. Nehar, M. Mishra, and K. Heese Identification and characterisation of the novel amyloid-beta peptide-induced protein p17 FEBS Lett. 583 2009 3247 3253
28. K. Heese, T. Yamada, H. Akatsu, T. Yamamoto, K. Kosaka, Y. Nagai, and T. Sawada Characterizing the new transcription regulator protein p60TRP J. Cell. Biochem. 91 2004 1030 1042
29. K.D. Pruitt, and D.R. Maglott RefSeq and LocusLink: NCBI gene-centered resources Nucleic Acids Res. 29 2001 137 140
30. M. Encinas, M. Iglesias, Y. Liu, H. Wang, A. Muhaisen, V. Cena, C. Gallego, and J.X. Comella Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells J. Neurochem. 75 2000 991 1003
31. M.J. Martinez-Lopez, S. Alcantara, C. Mascaro, F. Perez-Branguli, P. Ruiz-Lozano, T. Maes, E. Soriano, and C. Buesa Mouse neuron navigator 1, a novel microtubule-associated protein involved in neuronal migration Mol. Cell. Neurosci. 28 2005 599 612
32. P. Mookherjee, and G.V. Johnson Tau phosphorylation during apoptosis of human SH-SY5Y neuroblastoma cells Brain Res. 921 2001 31 43
33. P. Brundin, R. Melki, and R. Kopito Prion-like transmission of protein aggregates in neurodegenerative diseases Nat. Rev. Mol. Cell Biol. 11 2010 301 307
34. B. Frost, and M.I. Diamond Prion-like mechanisms in neurodegenerative diseases Nat. Rev. Neurosci. 11 2010 155 159
35. H. Braak, and K. Del Tredici Alzheimer's pathogenesis: is there neuron-to-neuron propagation? Acta Neuropathol. 121 2011 589 595
36. J.L. Guo, and V.M. Lee Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles J. Biol. Chem. 286 2011 15317 15331
37. B. Frost, R.L. Jacks, and M.I. Diamond Propagation of tau misfolding from the outside to the inside of a cell J. Biol. Chem. 284 2009 12845 12852